Kiora Pharmaceuticals, Inc. (KPRX)
Develops eye drop medicines to restore vision in inherited retinal diseases.
$2.53-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-0.4%
The outlook
Kiora Pharmaceuticals trades at $2.53, sitting midway through its 52-week range with mixed momentum against recent averages. Analyst price targets average around $11.97, roughly 374% above the current price, though coverage appears limited. The overall lean is bullish based on available data, though the stock shows no clear directional movement today.
What’s behind the score
Price trendMixed vs its moving averages
52-week range61% of the way from its 52-week low to high
Price targetAvg target +374% vs current price
Market cap
$11.2M
52-wk high
$3.01
52-wk low
$1.77
50-day avg
$2.59
200-day avg
$2.31
Trailing P/E
—